PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.51%
Revenue growth under 50% of QCOM's 14.66%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.75%
Gross profit growth under 50% of QCOM's 18.58%. Michael Burry would be concerned about a severe competitive disadvantage.
2.63%
EBIT growth below 50% of QCOM's 33.15%. Michael Burry would suspect deeper competitive or cost structure issues.
2.40%
Operating income growth under 50% of QCOM's 33.15%. Michael Burry would be concerned about deeper cost or sales issues.
2.95%
Net income growth under 50% of QCOM's 21.48%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.03%
EPS growth under 50% of QCOM's 21.77%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.96%
Diluted EPS growth under 50% of QCOM's 21.63%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.11%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.21%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.20%
Dividend growth above 1.5x QCOM's 0.05%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-9.04%
Negative OCF growth while QCOM is at 90.99%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
58.23%
FCF growth under 50% of QCOM's 127.82%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
94.62%
10Y revenue/share CAGR under 50% of QCOM's 242.63%. Michael Burry would suspect a lasting competitive disadvantage.
55.90%
5Y revenue/share CAGR under 50% of QCOM's 134.65%. Michael Burry would suspect a significant competitive gap or product weakness.
38.84%
3Y revenue/share CAGR under 50% of QCOM's 138.59%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
491.32%
10Y OCF/share CAGR above 1.5x QCOM's 73.23%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
191.60%
5Y OCF/share CAGR above 1.5x QCOM's 96.15%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
97.03%
3Y OCF/share CAGR under 50% of QCOM's 523.56%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
928.53%
Net income/share CAGR above 1.5x QCOM's 263.49% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
138.70%
Below 50% of QCOM's 555.35%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
83.99%
Below 50% of QCOM's 243.46%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
56.79%
Positive growth while QCOM is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
42.46%
Positive 5Y equity/share CAGR while QCOM is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
67.39%
Below 50% of QCOM's 238.14%. Michael Burry suspects a serious short-term disadvantage in building book value.
575.06%
10Y dividend/share CAGR above 1.5x QCOM's 216.61%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
129.88%
5Y dividend/share CAGR above 1.5x QCOM's 28.31%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
49.37%
3Y dividend/share CAGR above 1.5x QCOM's 10.08%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
5.53%
AR growth is negative/stable vs. QCOM's 12.66%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
7.85%
Inventory shrinking or stable vs. QCOM's 19.61%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.43%
Asset growth at 50-75% of QCOM's 3.83%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
5.24%
Under 50% of QCOM's 14.41%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-5.65%
We’re deleveraging while QCOM stands at 0.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
0.51%
R&D dropping or stable vs. QCOM's 2.77%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
4.46%
We expand SG&A while QCOM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.